BEAMSTART Logo

HomeCompaniesProfile

TorMagnus Pharmaceuticals

Leveraging genetics and computation to find new therapies for disease. 


Company Size

1 - 5 employees

Year Founded

2022


About TorMagnus Pharmaceuticals

At TorMagnus, we’re leveraging genetics and computation to identify new treatments for disease, starting with Parkinson's disease.

Financials Beta

Business Model: Not Specified

Revenues: Not Specified

Expenses: Not Specified

Debt: Request

Operating Status: Active

Funding Raised: $0

Investment Rounds: 0 Rounds

Funding Stage: Not Specified

Last Funding Date: Not Specified


Frequently Asked Questions

What industry is TorMagnus Pharmaceuticals in?

TorMagnus Pharmaceuticals is in the Biotech, Healthcare, and Medtech industry.

How long has TorMagnus Pharmaceuticals been in business?

TorMagnus Pharmaceuticals was established in 2022 (3 years in business).

Is TorMagnus Pharmaceuticals currently hiring?

No, TorMagnus Pharmaceuticals is currently not hiring.

Visit TorMagnus Pharmaceuticals's Jobs Page to stay updated with any upcoming open positions.

Which country is TorMagnus Pharmaceuticals headquartered in?

TorMagnus Pharmaceuticals is based in United States.

Share This Profile

More Companies

Craze Production

Events Management & Corporate Gifts

Dialect

Making internet experiences distributable and actionable everywhere

BITSHARES LABS

We develop blockchain centric web and mobile apps

Propify

Plaid for Commercial Real Estate

MindsDB

AI that works at work. Turnkey. Private.

Harmoney

Electronic bond trading platform for institutions in India

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.